Qlucore AB (QCORE) - Total Liabilities
Based on the latest financial reports, Qlucore AB (QCORE) has total liabilities worth Skr11.36 Million SEK (≈ $1.22 Million USD) as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Qlucore AB (QCORE) cash conversion ratio to assess how effectively this company generates cash.
Qlucore AB - Total Liabilities Trend (2019–2025)
This chart illustrates how Qlucore AB's total liabilities have evolved over time, based on quarterly financial data. Check Qlucore AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Qlucore AB Competitors by Total Liabilities
The table below lists competitors of Qlucore AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nilsson Special Vehicles publ AB
ST:NILS
|
Sweden | Skr59.91 Million |
|
Ace Integrated Solutions Limited
NSE:ACEINTEG
|
India | Rs4.50 Million |
|
Bohra Industries Limited
NSE:BOHRAIND
|
India | Rs62.65 Million |
|
Treatt PLC
LSE:TET
|
UK | GBX33.85 Million |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
USA | $65.59 Million |
|
Direct Digital Holdings Inc
NASDAQ:DRCT
|
USA | $27.18 Million |
|
Afentra PLC
LSE:AET
|
UK | GBX121.12 Million |
|
British Smaller Companies Vct 2 Plc
LSE:BSC
|
UK | GBX515.00K |
Liability Composition Analysis (2019–2025)
This chart breaks down Qlucore AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Qlucore AB stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qlucore AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qlucore AB (2019–2025)
The table below shows the annual total liabilities of Qlucore AB from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | Skr11.49 Million ≈ $1.24 Million |
+5.40% |
| 2024-04-30 | Skr10.90 Million ≈ $1.17 Million |
-25.49% |
| 2023-04-30 | Skr14.63 Million ≈ $1.57 Million |
+29.03% |
| 2022-04-30 | Skr11.34 Million ≈ $1.22 Million |
+17.13% |
| 2021-04-30 | Skr9.68 Million ≈ $1.04 Million |
+14.57% |
| 2020-04-30 | Skr8.45 Million ≈ $909.03K |
-6.26% |
| 2019-04-30 | Skr9.01 Million ≈ $969.69K |
-- |
About Qlucore AB
Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. It offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for m… Read more